some numbers from berlinheart

11.07.2005 200th LVAD INCOR® Patient

We would like to inform you that on the 11th of July the 200th patient has been treated with our implantable INCOR® LVAD. The 61-year old man from...


30.11.2007
300th INCOR® LVAD Implanted

The 300th INCOR® LVAD was implanted in late October 2006 at the German Heart Institute Berlin.

The 53-year-old patient (1.92m height, 110kg body weight) was suffering from dilated cardio-myopathy and mitral valve insufficiency. He had already received an implanted defibrillator. When his condition did not improve, he was listed for a heart transplantation, and finally, as his condition continued to worsen, was put on the high urgency list.

In late October 2006 the patient received an INCOR® LVAD with long inflow cannula through medial implant. The operation, conducted by Professor Yuguo Weng, went without complications. The patient recovered well and was discharged from the hospital in late November 2006. He has resumed his normal life and enjoys the daily walks with his dog.

18.02.2007

Second INCOR® Patient with more than Three Years on the Device


A 63-year-old from Northern France is the second INCOR® patient living with the system for more than three years.

The Frenchman had been diagnosed with idiopathic cardiomyopathy in the summer of 2003. Prior to the implantation he had sustained two myocardial infarcts and had developed a recidivating pulmonary edema.

In early August 2003 the then 59-year-old received an INCOR® LVAD with short inflow cannula through medial implant at the CHU Henri Mondor in Créteil. Professor Daniel Loisance con-ducted the implantation that went without complications. The patient recovered well and was extubated a day after the implantation. He was discharged from the hospital early and receives an anticoagulation therapy with low weight molecular heparin. The patient has been living at home for more than three years now.

The 63-year-old was the first patient in France and the 61st patient worldwide to receive an INCOR® LVAD. Due to patient-specific circumstances the Frenchman cannot receive a heart transplantation and received the INCOR® with the indication Destination Therapy.

The INCOR® LVAD was first implanted during a clinical study in June 2002. In March 2003 INCOR® received CE mark approval and in the meanwhile has been implanted in 317 patients.

http://www.berlinheart.de/englisch/allgemein/news/Presse/index.php


From VCR

Mr. Crosby added, As of 15 May 2007, there have been 113 patients implanted with the VentrAssistTM Left Ventricular Assist Device (LVAD), who have collectively enjoyed about 53 patient years of support, with the longest duration of support two years and eight months. This is the greatest clinical experience of any third generation centrifugal LVAD, and we believeputs us in an enviable competitive position globally.